.png)
Small Diagnostics
Medical Affairs, Marketing, Commercial
Pre-Launch Phase
Gastroenterology
Subscribe to our newsletter to receive the latest case studies.
Small Diagnostics
Medical Affairs, Marketing, Commercial
Pre-Launch Phase
Gastroenterology
The client was preparing to launch a novel diagnostic test intended to improve patient identification and treatment decisions.
While the test demonstrated technical promise, adoption would depend on whether key decision-makers viewed it as meaningfully improving clinical decision-making.
The client engaged Alkemi to understand how the test would be evaluated in practice and what evidence and positioning would be required to support adoption.
1. Convened a Key Opinion Leader (KOL) advisory board to capture expert perspectives on clinical relevance and decision impact.
2. Reviewed comparable diagnostic technologies to understand how evidence had influenced adoption and reimbursement decisions.
3. Synthesized insights into a focused report outlining key findings, strategic implications, and recommended next steps.
Clarify what evidence and messages would change decision-maker behavior.
"Thank you for bringing us along throughout this process, you told us exactly what we needed to hear." - CEO
The team gained clarity on what evidence and outcomes would matter most to decision-makers.
Insights showed the initial approach was unlikely to influence adoption, allowing the team to refocus early.
The client aligned around a revised strategy and began implementing recommended changes ahead of launch.